Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction.

However, there was a 38% increased frequency of loss of CDKN2A/B mutation in progressors that was not seen in non-progressors, but this did not reach statistical significance.

also in 111,027 other papers